{"id":534254,"date":"2021-09-03T07:03:12","date_gmt":"2021-09-03T11:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/"},"modified":"2021-09-03T07:03:12","modified_gmt":"2021-09-03T11:03:12","slug":"renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/","title":{"rendered":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK and SALT LAKE CITY, Sept.  03, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u5o6TzNqm3U7j5YaYg0cU6ReWEspQNVZA4bqmBTKPetVHHzZM_iUKsklr9v8Em4ZS3D_Menko6xxAZ7lGQjRlA==\" rel=\"nofollow noopener\" target=\"_blank\">Renalytix plc<\/a> (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference.<\/p>\n<p>Renalytix\u2019s management is scheduled to participate in a fireside chat Friday, September 10 at 2:40 p.m. EDT. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xy6TUbKqkE2op2oX8g5HfeiS63MY7sHwJ2GU3yrjyDFpmNPQVmfRakhmSHIr1VwkzyfE10crw4WjdCS28LQWVuGAMyi3OmzikY5vgGw2tNM=\" rel=\"nofollow noopener\" target=\"_blank\">investors.renalytix.com<\/a>.<\/p>\n<p>\n        <strong>About Renalytix<\/strong><br \/>\n        <br \/>Renalytix (LSE: RENX) (NASDAQ: RNLX) Renalytix is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company\u2019s lead product is KidneyIntelX\u2122, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v_uwUGYmHo9jLKfckD9Ga9NQs1b53eh1ybotZMf4gJAsLXJebXLwIz3nerdmFW1QoVDzRMJB7L9Rfw06mbgN52eKUuepEGqx4XCsH34DRFhzT5nzEPBSubwJAGmWDm3MGNy2Sb49oK9TTGaTF6u7JLyAVJT-ZJUE10__Dq5vOVdJZsN9vU30EinjBx_pcOnQsv6FVPsBPbSrjJmJOt3u2Xe-Wu0PGS_3YnSBqmyAeIhEG-FIBvEbHtkeiYZ1tkhvj3mOYmfEZl_8fStNXELfOA==\" rel=\"nofollow noopener\" target=\"_blank\">www.kidneyintelx.com<\/a>). For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GOeM2UTv5xLxOx7g4aaGIZlyDgLHgsz0GBxaXK4aJ3lm6ej8wnZND2fSTJ7WfZaqzwDnFJTWe3iaL46TRNkfBAyIokKApNPBoBUtxR3YN0pSC-kUILmU9GZ5AD5z30eJZW81vNnji7qx7y0KwWiExzBpzVYMN6V8LDfRkN1d467LUpHJ-_gSF6S4x8NFJxVsK6W-s28V9zACFthvReFvX8vRUyUmSLLVly1CNhy5LI0=\" rel=\"nofollow noopener\" target=\"_blank\">www.renalytix.com<\/a>.<\/p>\n<p>\n        <strong>UK Investor Contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:45%;width:45%;min-width:45%;vertical-align: middle\">Walbrook PR\u00a0Limited<\/td>\n<td colspan=\"2\" style=\"max-width:55%;width:55%;min-width:55%;vertical-align: middle\">\n            <strong>Tel: 020 7933 8780\u00a0<\/strong>or\u00a0<a href=\"mailto:renalytix@walbrookpr.com\" rel=\"nofollow noopener\" target=\"_blank\"><u>renalytix@walbrookpr.com<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">Paul McManus \/ Lianne Cawthorne<\/td>\n<td colspan=\"2\" style=\"vertical-align: middle\">Mob: 07980 541 893 \/ 07584 391 303<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>US Investor Contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: middle\">CapComm Partners<\/td>\n<td colspan=\"2\" style=\"vertical-align: middle\">\n            <a href=\"mailto:investors@renalytix.com\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <u>investors@renalytix.com<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\" style=\"vertical-align: middle\">Peter DeNardo<\/td>\n<td style=\"vertical-align: middle\">415-389-6400<\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODI4MWI0M2ItN2MzNi00YWE2LWI0NGQtYjQ2YzJlNDNjN2M4LTEyMTI1NzM=\/tiny\/Renalytix-AI-plc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference. Renalytix\u2019s management is scheduled to participate in a fireside chat Friday, September 10 at 2:40 p.m. EDT. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. About Renalytix Renalytix (LSE: RENX) (NASDAQ: RNLX) Renalytix is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company\u2019s lead product &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534254","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference. Renalytix\u2019s management is scheduled to participate in a fireside chat Friday, September 10 at 2:40 p.m. EDT. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. About Renalytix Renalytix (LSE: RENX) (NASDAQ: RNLX) Renalytix is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company\u2019s lead product &hellip; Continue reading &quot;Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-03T11:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference\",\"datePublished\":\"2021-09-03T11:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/\"},\"wordCount\":211,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/\",\"name\":\"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\",\"datePublished\":\"2021-09-03T11:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk","og_description":"NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference. Renalytix\u2019s management is scheduled to participate in a fireside chat Friday, September 10 at 2:40 p.m. EDT. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. About Renalytix Renalytix (LSE: RENX) (NASDAQ: RNLX) Renalytix is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company\u2019s lead product &hellip; Continue reading \"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-03T11:03:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference","datePublished":"2021-09-03T11:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/"},"wordCount":211,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/","name":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=","datePublished":"2021-09-03T11:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTgwMCM0Mzg3ODYwIzIyMDEwMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534254"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}